Skip to content

Clinical trials

Phase 1 Adenocarcinoma of Lung trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Phase 1 Status: Unknown status Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20161
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Garden State Cancer Center at the Center for Molecular Medicine and Immunology1
Jonsson Comprehensive Cancer Center1
Multitude Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung4
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms2
Adenocarcinoma, Bronchiolo-Alveolar1
Burkitt Lymphoma1
Carcinoma1
Carcinoma, Ovarian Epithelial1
Endometrial Neoplasms1
Hodgkin Disease1
Immunoblastic Lymphadenopathy1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.